Case counts and crude rates by city, sex, age at exposure, attained age, calendar year of diagnosis and radiation dose: Hodgkin lymphoma, mature B-cell neoplasms, mature T-/NK-cell neoplasms, precursor cell neoplasms and other subtypes, LSS, 1950 to 1994
| . | . | Hodgkin lymphoma . | Mature B-cell neoplasms . | Mature T-cell and NK-cell neoplasms . | Precursor cell neoplasms . | Lymphoid neoplasm, non-Hodgkin lymphoma and NOS . |
|---|---|---|---|---|---|---|
| . | Person-years (x100 000) . | 15 Cases (%) . | 319 Cases (%) . | 108 Cases (%) . | 30 Cases (%) . | 81 Cases (%) . |
| City | ||||||
| Hiroshima | 23.2 | 10 (66.7) | 247 (77.4) | 47 (43.5) | 25 (83.3 | 4 (55.6) |
| Nagasaki | 9.4 | 5 (33.3) | 72 (22.6) | 61 (56.5) | 5 (16.7) | 36.(44.4) |
| Sex | ||||||
| Female | 20.2 | 9 (60.0) | 141 (44.2) | 57 (52.8) | 14 (46.7) | 32 (39.5) |
| Male | 12.5 | 6 (40.0) | 178 (55.8) | 51 (47.2) | 16 (53.3) | 49 (60.5) |
| Crude rates per 100 000 person-y (no. of cases) | ||||||
| Age at exposure, y | ||||||
| <20 | 15.1 | 0.4 (6) | 3.7 (56) | 2.1 (31) | 1.2 (18) | 1.1 (16) |
| 20-39 | 10.6 | 0.5 (5) | 14.9 (157) | 4.2 (44) | 0.8 (8) | 2.9 (31) |
| 40+ | 6.7 | 0.6 (4) | 15.8 (106) | 4.9 (33) | 0.6 (4) | 5.1 (34) |
| Attained age, y | ||||||
| <20 | 2.2 | 0.5 (1) | 0.0 (0) | 0.5 (1) | 2.7 (6) | 0.9 (2) |
| 20-39 | 8.2 | 0.6 (5) | 0.7 (6) | 1.0 (8) | 0.9 (7) | 1.2 (10) |
| 40-59 | 12.3 | 0.2 (2) | 5.0 (62) | 3.3 (41) | 0.7 (9) | 1.5 (19) |
| 60+ | 9.7 | 0.7 (7) | 25.8 (251) | 6.0 (58) | 0.8 (8) | 5.1 (50) |
| Calendar period, y | ||||||
| 1950-1959 | 7.2 | 0.1 (1) | 2.5 (18) | 0.8 (7) | 1.3 (12) | 1.6 (14) |
| 1960-1969 | 8.6 | 0.8 (7) | 4.3 (37) | 3.4 (28) | 0.7 (6) | 2.5 (21) |
| 1970-1979 | 7.2 | 0.7 (5) | 11.4 (82) | 3.6 (25) | 0.7 (5) | 2.3 (16) |
| 1980-1989 | 6.0 | 0.2 (1) | 20.1 (120) | 5.7 (33) | 0.9 (5) | 2.7 (16) |
| 1990-1994 | 3.4 | 0.4 (1) | 18.1 (62) | 6.3 (15) | 0.8 (2) | 5.9 (14) |
| Bone marrow dose, Gy | ||||||
| NIC | 7.6 | 0.4 (3) | 9.7 (74) | 2.5 (19) | 0.3 (2) | 2.2 (17) |
| <0.005 | 10.7 | 0.4 (4) | 9.5 (102) | 3.9 (42) | 0.5 (5) | 3.4 (36) |
| 0.005 to <1.0 | 8.5 | 0.6 (5) | 9.9 (84) | 3.1 (26) | 0.5 (4) | 2.0 (17) |
| 0.1 to <0.03 | 2.7 | 0.0 (0) | 11.6 (31) | 3.4 (9) | 0.7 (2) | 0.7 (2) |
| 0.3 to <1.0 | 2.1 | 1.4 (3) | 9.6 (20) | 5.3 (11) | 2.9 (6) | 1.9 (4) |
| 1.0 to <2.0 | 0.5 | 0.0 (0) | 5.5 (3) | 1.8 (1) | 5.5 (3) | 7.3 (4) |
| 2.0+ | 0.2 | 0.0 (0) | 23.1 (5) | 0.0 (0) | 36.9 (8) | 4.6 (1) |
| . | . | Hodgkin lymphoma . | Mature B-cell neoplasms . | Mature T-cell and NK-cell neoplasms . | Precursor cell neoplasms . | Lymphoid neoplasm, non-Hodgkin lymphoma and NOS . |
|---|---|---|---|---|---|---|
| . | Person-years (x100 000) . | 15 Cases (%) . | 319 Cases (%) . | 108 Cases (%) . | 30 Cases (%) . | 81 Cases (%) . |
| City | ||||||
| Hiroshima | 23.2 | 10 (66.7) | 247 (77.4) | 47 (43.5) | 25 (83.3 | 4 (55.6) |
| Nagasaki | 9.4 | 5 (33.3) | 72 (22.6) | 61 (56.5) | 5 (16.7) | 36.(44.4) |
| Sex | ||||||
| Female | 20.2 | 9 (60.0) | 141 (44.2) | 57 (52.8) | 14 (46.7) | 32 (39.5) |
| Male | 12.5 | 6 (40.0) | 178 (55.8) | 51 (47.2) | 16 (53.3) | 49 (60.5) |
| Crude rates per 100 000 person-y (no. of cases) | ||||||
| Age at exposure, y | ||||||
| <20 | 15.1 | 0.4 (6) | 3.7 (56) | 2.1 (31) | 1.2 (18) | 1.1 (16) |
| 20-39 | 10.6 | 0.5 (5) | 14.9 (157) | 4.2 (44) | 0.8 (8) | 2.9 (31) |
| 40+ | 6.7 | 0.6 (4) | 15.8 (106) | 4.9 (33) | 0.6 (4) | 5.1 (34) |
| Attained age, y | ||||||
| <20 | 2.2 | 0.5 (1) | 0.0 (0) | 0.5 (1) | 2.7 (6) | 0.9 (2) |
| 20-39 | 8.2 | 0.6 (5) | 0.7 (6) | 1.0 (8) | 0.9 (7) | 1.2 (10) |
| 40-59 | 12.3 | 0.2 (2) | 5.0 (62) | 3.3 (41) | 0.7 (9) | 1.5 (19) |
| 60+ | 9.7 | 0.7 (7) | 25.8 (251) | 6.0 (58) | 0.8 (8) | 5.1 (50) |
| Calendar period, y | ||||||
| 1950-1959 | 7.2 | 0.1 (1) | 2.5 (18) | 0.8 (7) | 1.3 (12) | 1.6 (14) |
| 1960-1969 | 8.6 | 0.8 (7) | 4.3 (37) | 3.4 (28) | 0.7 (6) | 2.5 (21) |
| 1970-1979 | 7.2 | 0.7 (5) | 11.4 (82) | 3.6 (25) | 0.7 (5) | 2.3 (16) |
| 1980-1989 | 6.0 | 0.2 (1) | 20.1 (120) | 5.7 (33) | 0.9 (5) | 2.7 (16) |
| 1990-1994 | 3.4 | 0.4 (1) | 18.1 (62) | 6.3 (15) | 0.8 (2) | 5.9 (14) |
| Bone marrow dose, Gy | ||||||
| NIC | 7.6 | 0.4 (3) | 9.7 (74) | 2.5 (19) | 0.3 (2) | 2.2 (17) |
| <0.005 | 10.7 | 0.4 (4) | 9.5 (102) | 3.9 (42) | 0.5 (5) | 3.4 (36) |
| 0.005 to <1.0 | 8.5 | 0.6 (5) | 9.9 (84) | 3.1 (26) | 0.5 (4) | 2.0 (17) |
| 0.1 to <0.03 | 2.7 | 0.0 (0) | 11.6 (31) | 3.4 (9) | 0.7 (2) | 0.7 (2) |
| 0.3 to <1.0 | 2.1 | 1.4 (3) | 9.6 (20) | 5.3 (11) | 2.9 (6) | 1.9 (4) |
| 1.0 to <2.0 | 0.5 | 0.0 (0) | 5.5 (3) | 1.8 (1) | 5.5 (3) | 7.3 (4) |
| 2.0+ | 0.2 | 0.0 (0) | 23.1 (5) | 0.0 (0) | 36.9 (8) | 4.6 (1) |